Table 2

Incidence rates and rate differences of heart failure (per 1000 person-years) comparing sarcoidosis with the general population, overall and by age at start of follow-up, sex, sarcoidosis treatment status around sarcoidosis diagnosis, time since sarcoidosis diagnosis, and history of ischaemic heart disease or acute myocardial infarction

SarcoidosisGeneral populationRate difference*
(95% CI)
Events/
N at risk
Incidence rate*
(95% CI)
Events/
N at risk
Incidence rate*
(95% CI)
Overall204/85742.2 (1.9 to 2.6)721/84 1920.7 (0.7 to 0.8)1.5 (1.1 to 1.8)
Age at start of follow-up, years
 18–4418/36990.8 (0.5 to 1.3)53/36 5490.2 (0.2 to 0.3)0.6 (0.2 to 1.0)
 45–6468/33943.3 (2.6 to 4.3)225/33 5781.1 (0.9 to 1.3)2.2 (1.4 to 3.1)
 65–85118/148119.0 (15.8 to 22.9)443/14 0656.6 (5.9 to 7.3)12.5 (8.9 to 16.0)
Sex
 Female90/38241.8 (1.4 to 2.4)329/37 6060.6 (0.5 to 0.8)1.2 (0.8 to 1.6)
 Male114/47502.4 (2.0 to 3.0)392/46 5860.8 (0.7 to 0.9)1.6 (1.2 to 2.1)
Sarcoidosis treatment around diagnosis†
 Treated62/26963.0 (2.2 to 4.1)161/26 4790.7 (0.6 to 0.9)2.3 (1.4 to 3.1)
 Untreated79/38892.1 (1.6 to 2.8)234/38 1200.6 (0.5 to 0.8)1.5 (1.0 to 2.0)
Time since sarcoidosis diagnosis, years
 ≤298/85741.2 (0.9 to 1.5)223/84 1920.5 (0.4 to 0.6)0.7 (0.4 to 0.9)
 >2106/65851.0 (0.8 to 1.3)498/65 9490.2 (0.2 to 0.3)0.8 (0.5 to 1.0)
History of ischaemic heart disease or acute myocardial infarction
 Yes37/33926.9 (19.4 to 37.4)186/273513.6 (11.5 to 16.1)13.3 (4.4 to 22.2)
 No167/82352.1 (1.8 to 2.5)535/81 4570.6 (0.6 to 0.7)1.5 (1.1 to 1.8)
  • *Rates and rate differences per 1000 person-years were estimated using Poisson regression models adjusted for age, sex (if applicable) and region of residence.

  • †Evaluated in individuals with start of follow-up from 2006 and onwards for whom medication dispensation data were available in the Prescribed Drug Register.